Veritas Intercontinental

Veritas Intercontinental, a biotechnology and life sciences startup founded in 2018 in Spain, is dedicated to utilizing genetic and genomic diagnostics to enhance and extend lives. The company's global portfolio encompasses preventive medicine, perinatal medicine, and genomic diagnostic services. Their slogan, "🧬Sequencing your genome is the first step in a life-changing journey," reflects their commitment to leveraging science and global resources for the betterment of individuals' health. In March 2022, Veritas announced its integration with LetsGetChecked, a global healthcare solutions company based in Dublin and New York. This strategic move aims to further the reach and impact of Veritas' offerings. The most recent significant development for the company was a €5.00M Series A investment on July 5, 2020, from a consortium of investors including Amadeus Capital Partners, Stemar Capital, Charme Capital Partners, and Javier de Echevarría. Veritas Intercontinental prioritizes collaboration with healthcare providers, governments, and local communities to make genetic and genomic medicine accessible and affordable on a global scale. For more information, interested individuals can visit their website: www.veritasint.com.